© 2000 American Heart Association, Inc.
Cellular Biology |
Hyperaldosteronemia in Rabbits Inhibits the Cardiac Sarcolemmal Na+-K+ Pump
From the Department of Cardiology, Royal North Shore Hospital (A.S.M., M.M., P.S.H., H.H.R.) and The University of Sydney (M.M., P.S.H., H.H.R.), Sydney, Australia, and Department of Medicine (H.B., K.K.), The Heart Centre, Rigshospitalet, National University Hospital, Copenhagen, Denmark.
Correspondence to Professor H.H. Rasmussen, Department of Cardiology, Royal North Shore Hospital, Pacific Highway, St. Leonards, Sydney, NSW, Australia 2065. E-mail helger{at}mail.med.usyd.edu.au
Abstract—Aldosterone upregulates the Na+-K+ pump in kidney and colon, classical target organs for the hormone. An effect on pump function in the heart is not firmly established. Because the myocardium contains mineralocorticoid receptors, we examined whether aldosterone has an effect on Na+-K+ pump function in cardiac myocytes. Myocytes were isolated from rabbits given aldosterone via osmotic minipumps and from controls. Electrogenic Na+-K+ pump current, arising from the 3:2 Na+:K+ exchange ratio, was measured in single myocytes using the whole-cell patch clamp technique. Treatment with aldosterone induced a decrease in pump current measured when myocytes were dialyzed with patch pipette solution containing Na+ in a concentration of 10 mmol/L, whereas there was no effect measured when the solution contained 80 mmol/L Na+. Aldosterone had no effect on myocardial Na+-K+ pump concentration evaluated by vanadate-facilitated [3H]ouabain binding or by K+-dependent paranitrophenylphosphatase activity in crude homogenates. Aldosterone induced an increase in intracellular Na+ activity. The aldosterone-induced decrease in pump current and increased intracellular Na+ were prevented by cotreatment with the mineralocorticoid receptor antagonist spironolactone. Our results indicate that hyperaldosteronemia decreases the apparent Na+ affinity of the Na+-K+ pump, whereas it has no effect on maximal pump capacity.
Key Words: cardiac • mineralocorticoid receptor • spironolactone • ouabain binding • sodium
This article has been cited by other articles:
 |
|
 |
|
  V. McEneaney, B. J. Harvey, and W. Thomas Aldosterone Regulates Rapid Trafficking of Epithelial Sodium Channel Subunits in Renal Cortical Collecting Duct Cells via Protein Kinase D Activation Mol. Endocrinol., April 1, 2008; 22(4): 881 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C De Mello Beneficial Effect of Eplerenone on Cardiac Remodelling and Electrical Properties of the Failing Heart Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1): 40 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Yamamuro, M. Yoshimura, M. Nakayama, K. Abe, M. Shono, S. Suzuki, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al. Direct Effects of Aldosterone on Cardiomyocytes in the Presence of Normal and Elevated Extracellular Sodium Endocrinology, March 1, 2006; 147(3): 1314 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Perrier, S. Richard, Y. Sainte-Marie, B. C. Rossier, F. Jaisser, E. Hummler, and J.-P. Benitah A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice J. Physiol., November 15, 2005; 569(1): 153 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Funder The Nongenomic Actions of Aldosterone Endocr. Rev., May 1, 2005; 26(3): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Mihailidou Nongenomic Cardiovascular Actions of Aldosterone: A Receptor for All Seasons? Endocrinology, March 1, 2005; 146(3): 971 - 972. [Full Text] [PDF]
|
|
|
|
|
|
A. S. Mihailidou, M. Mardini, and J. W. Funder Rapid, Nongenomic Effects of Aldosterone in the Heart Mediated by {epsilon} Protein Kinase C Endocrinology, February 1, 2004; 145(2): 773 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arima, K. Kohagura, H.-L. Xu, A. Sugawara, A. Uruno, F. Satoh, K. Takeuchi, and S. Ito Endothelium-Derived Nitric Oxide Modulates Vascular Action of Aldosterone in Renal Arteriole Hypertension, February 1, 2004; 43(2): 352 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arima, K. Kohagura, H.-L. Xu, A. Sugawara, T. Abe, F. Satoh, K. Takeuchi, and S. Ito Nongenomic Vascular Action of Aldosterone in the Glomerular Microcirculation J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2255 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. White Aldosterone: Direct Effects on and Production by the Heart J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2376 - 2383. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cittadini, M. G. Monti, J. Isgaard, C. Casaburi, H. Stromer, A. Di Gianni, R. Serpico, L. Saldamarco, M. Vanasia, and L. Sacca Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure Cardiovasc Res, June 1, 2003; 58(3): 555 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Alzamora, E. T. Marusic, M. Gonzalez, and L. Michea Nongenomic Effect of Aldosterone on Na+,K+-Adenosine Triphosphatase in Arterial Vessels Endocrinology, April 1, 2003; 144(4): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H.G Schwinger, H. Bundgaard, J. Muller-Ehmsen, and K. Kjeldsen The Na, K-ATPase in the failing human heart Cardiovasc Res, March 15, 2003; 57(4): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Kjeldsen, A Norgaard, and M Gheorghiade Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure Cardiovasc Res, September 1, 2002; 55(4): 710 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Crambert, M. Fuzesi, H. Garty, S. Karlish, and K. Geering Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties PNAS, August 20, 2002; 99(17): 11476 - 11481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Mihailidou, M. Mardini, J. W. Funder, and M. Raison Mineralocorticoid and Angiotensin Receptor Antagonism During Hyperaldosteronemia Hypertension, August 1, 2002; 40(2): 124 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. G. Glitsch Electrophysiology of the Sodium-Potassium-ATPase in Cardiac Cells Physiol Rev, October 1, 2001; 81(4): 1791 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mardini, A. S. Mihailidou, A. Wong, and H. H. Rasmussen Cyclosporine and FK506 Differentially Regulate the Sarcolemmal Na+-K+ Pump J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 804 - 810. [Abstract] [Full Text]
|
|
|
|
|
|
O. M. Sejersted and G. Sjogaard Dynamics and Consequences of Potassium Shifts in Skeletal Muscle and Heart During Exercise Physiol Rev, October 1, 2000; 80(4): 1411 - 1481. [Abstract] [Full Text] [PDF]
|
|